Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.22.1
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended
Mar. 22, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 21, 2022
Dec. 31, 2021
Apr. 18, 2019
Dec. 11, 2017
Subsidiary, Sale of Stock [Line Items]              
Common stock, share authorized 100,000,000   100,000,000 50,000,000 100,000,000 50,000,000 20,000,000
Common stock, par value     $ 0.0001   $ 0.0001   $ 0.0001
Preferred stock, shares authorized 1,000,000   1,000,000 10,000 1,000,000 10,000  
Preferred stock, par value $ 0.0001   $ 0.0001 $ 0.001 $ 0.0001 $ 0.001  
Conversion of Stock, Description Pursuant to the merger agreement, (i) the Company merged with and into Sharps Nevada, (ii) each 3.5 shares of common stock of the Company were converted into one share of common stock of Sharps Nevada and (iii) the articles of incorporation and bylaws of Sharps Nevada, became the articles of incorporation and bylaws of the surviving corporation.            
Common Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Issuance of shares   14,286          
Private Placement [Member] | Common Stock [Member]              
Subsidiary, Sale of Stock [Line Items]              
Issuance of shares   187,143          
Share price   $ 7.00          
Proceeds from issuance of private placement   $ 1,310,000